AI application launched for COVID-19 pneumonia detection

BioMind has launched an artificial intelligence (AI) application to assist in the detection of COVID-19 associated pneumonia on medical imaging. The AI application identifies anomalies in the lungs and assists in detection of COVID-19 pneumonia. It analyses the lung pathology on chest CT to aid in the assessment and comes with triage capability. With the sudden surge in admission of respiratory-related patients globally, triaging can help to reduce the increasing burden on the intensive care units (ICU) and address the shortage of medical resources. Raymond Moh, CEO of BioMind, said: "We are proud to receive the Health Sciences Authority's approval for our COVID-19 diagnostics support product. This was born out of the immense efforts and collaborations between clinicians, lung specialists and our engineers. In an unprecedented crisis like this, we hope to quickly scale our solution in Asia, Europe, Middle East and USA to equip physicians with smart tools to detect and manage COVID-19 pneumonia. Artificial intelligence will be their useful assistant daily in this long battle."